Pharmaceutical historian Vol. 47. 2017, No. 2 by unknown
PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/2
PHARMACEUTICAL HISTORIAN
An International Journal for the History of Pharmacy 
Volume 47 Number 2   –   June 2017
Contents
Editorial
STUART ANDERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  19
Message from the President of the International Society for the History of Pharmacy  
CHRISTA KLETTER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  20
Message from the President of the British Society for the History of Pharmacy  
ROY ALLCORN . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  20
Articles
‘The rejection of tradition in favour of experience’: The publication of British 
pharmaceutical texts abroad 1670 to 1890
STUART ANDERSON . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  21
Establishing the provenance of a medicine chest belonging to Sir Walter Raleigh 
(c.1552 to 1618)
CHRISTOPHER J DUFFIN  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  33
Moodeen Sheriff and the 1869 Supplement to the Pharmacopoeia of India 1868
HARKISHAN SINGH  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  39
Documents and sources
A note on clinical judgment and standardisation: Should old hospital pharmacopoeias be discarded? 
JOHN K CRELLIN  . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .  43
https://doi.org/10.24355/dbbs.084-202007291100-0
 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/2 21
A R T I C L E S
‘Th e rejection of tradition in favour of 
experience:’ Th e publication of British 
pharmaceutical texts abroad 1670 to 1890
Stuart Anderson
Abstract
Th is paper presents an analysis of Cowen’s study of the 
popularity of translations and re-printings of British 
pharmaceutical texts abroad. Around 260 translations 
and reprints of over 30 publications were published be-
tween 1677 and 1871. Th e London Pharmacopoeia was 
the most frequently reproduced, although the largest 
category was the dispensatories, representing 52% of all 
those published. British texts were most popular in 
Germany, accounting for 41% of the total; along with 
the Netherlands, Italy, France and the United States it 
accounted for 90%. Th e appearance of translations 
fl uctuated decade to decade, with geopolitical events 
having an important impact. Publications peaked be-
tween 1750 and 1800, accounting for 51% of all texts 
published abroad.
Introduction
During the eighteenth and nineteenth centuries British 
pharmaceutical texts achieved a popularity and infl u-
ence that extended far beyond the shores of the British 
Isles, and greatly exceeded the impact of those of any 
other nation. Yet we know surprisingly little about the 
origins of this phenomenon, the reasons for it, and how 
it was sustained over such a long period. But such texts 
played an important part in spreading pharmaceutical 
knowledge across Europe, America and elsewhere. 
Whilst the popularity and infl uence of British texts 
abroad has received little attention from historians, one 
notable exception is the work of the American pharma-
ceutical historian David Cowen. In 2001 he published 
the results of his historical and bibliographic study of 
the spread and infl uence of British pharmacopoeial and 
related literature; it appears in section VII of his book 
‘Pharmacopoeias and Related Literature in Britain and 
America, 1618 to 1847.’1 
In text and tables Cowen demonstrates the diversity 
of pharmaceutical texts published abroad, the range of 
countries where such publication took place, and the 
long time period over which this occurred. Th e picture 
presented is one of widespread infl uence in many places 
over many years. But to what extent were such publica-
tions more popular in some countries than in others? 
Was publication of texts steady over many decades, or 
did it proceed in fi ts and starts? Was publication equal-
ly spread between diff erent texts, or were some much 
more popular than others? And what was the time lag 
between publication in Britain and publication abroad? 
Cowen leaves readers to fi nd the answers to these ques-
tions themselves; they are the questions addressed in 
this paper.
Th e publication of pharmaceutical texts in Britain 
Pharmaceutical literature takes a great many forms; by 
the start of the seventeenth century there was already a 
wide range of printed materials available relating to 
medicines and how to prepare them. Some were based 
on the work of classical scholars such as Galen and Avi-
cenna; others were the work of more recent practition-
ers. Th e introduction of movable type and the printing 
press in Europe by Gutenberg in 1439 greatly facilitat-
ed the transmission of pharmaceutical knowledge. Pub-
lication of the Recettario fi orentino in Florence in 14982 
led to state-sponsored formularies or pharmacopoeias 
appearing in many countries over the following dec-
ades. Between 1600 and 1700 over 25 separate phar-
macopoeias were published, mainly in Europe.3 
In the sixteenth and seventeenth centuries pharma-
ceutical knowledge became increasingly codifi ed with 
the development of a number of distinct forms. In ad-
dition to offi  cial publications supplementary texts ap-
peared that expanded this knowledge; these often in-
cluded details such as how to collect medicinal plants, 
how to prepare medicines for administration, and the 
conditions for which medicines were recommended. 
Th ere were also volumes assembled by prominent phy-
sicians or medical societies, mostly written in Latin. In 
his study Cowen identifi ed fi ve main categories of Brit-
ish pharmaceutical texts that were printed abroad, and 
these provide a useful basis for analysis.4 Th ey include 
texts published mainly for professional use in dispens-
ing and prescribing, but exclude texts on therapeutics 
aimed specifi cally at physicians and works on domestic 
medicine.
Pharmacopoeias and conspectuses
Of the various categories of pharmaceutical literature 
the most important were the offi  cial pharmacopoeias. 
Cowen defi ned a pharmacopoeia as ‘a compendium of 
drugs and formulas which is intended to secure uni-
formity and standardisation of remedies, and which is 
made legally obligatory for a particular political juris-
diction, especially upon the pharmacists and pharma-
ceutical manufacturers of that jurisdiction’.5 He also 
noted that it ‘must be prepared by an offi  cial pharmaco-
poeia commission’, one that has the authority of a 
monarch, state or parliament. Pharmacopoeias usually 
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contained catalogues of simples, or single medicines, 
along with a collection of prescriptions and directions, 
established under the authority of the state as a means 
of setting standards and encouraging greater consisten-
cy in treatment, prescription and dosage. Many of the 
early pharmacopoeias were published by city states, and 
the extent of their jurisdiction was usually limited. In 
Britain between the early seventeenth and mid-nine-
teenth centuries three separate pharmacopoeias were 
published; the London Pharmacopoeia, the Edinburgh 
Pharmacopoeia and the Dublin Pharmacopoeia, each 
produced by the relevant College of Physicians. Th ey 
were all subsequently replaced by the British Pharmaco-
poeia, which was published for this specifi c purpose6 
(Table 1).
Following publication of the fi rst edition of the London 
Pharmacopoeia in 1618 two further editions were pro-
duced in the seventeenth century, although periodic 
reprints appeared.7 A further three editions appeared 
during the eighteenth century. With the fourth edition, 
published in 1721 under the direction of Sir Hans 
Sloane (1660-1753), a serious eff ort was made to delete 
many obsolete and irrational remedies, and to replace 
them with new chemical preparations.8 Th e preface 
claimed that ‘all remedies owing their use to supersti-
tion and false philosophy’ had been thrown out. In-
deed, Wootton claims that the transition from the ‘old’ 
to the ‘new’ pharmacy can be traced to this volume.9 
Th e botanical names of plants were included for the 
fi rst time. 
Further attempts at modernisation were made in 
the fi fth edition, published in 1746. By the sixth edi-
tion, in 1788, the College claimed to have paid particu-
lar attention to ‘the applications of the advances of 
chemistry to pharmacy’. Th e seventh edition, in 1809, 
introduced the new chemical nomenclature; nearly 100 
items were deleted and a similar number added. Ra-
tionalisation continued with the eighth edition, al-
though morphine, iodine and quinine were omitted, 
despite their use being widely established in medical 
practice.10 Richard Phillips, a pharmacist, subsequently 
undertook the revisions resulting in the ninth edition.11 
Th is included many new products as well as methods 
for determining the purity of medicines and for prepar-
ing chemicals.
Th e fi rst edition of the Edinburgh Pharmacopoeia 
appeared in 1699, 80 years after the London one. Un-
like their London counterparts, the Royal College of 
Physicians of Edinburgh attempted, with considerable 
success, to issue revised editions every 10 to 12 years. 
Seven further editions appeared during the eighteenth 
century.12 With the 1774 edition many changes were 
made to bring the publication up to date; as in Lon-
don, reform was led by a leading fi gure amongst the 
physicians; Sir John Pringle (1707-1782) insisted that 
most of the obsolete materia medica be deleted.13 Four 
editions were published during the fi rst half of the 








1618 (fi rst edition) 1699 (fi rst edition) 1793 (fi rst specimen) 1864 (fi rst edition)
1621 (reprint) 1722 (second edition) 1805 (second specimen) 1867 (second edition)
1632 (reprint) 1735 (third edition) 1807 (fi rst edition) 1885 (third edition)
1639 (reprint) 1744 (fourth edition) 1826 (second edition) 1885 (Indian edition) 
1650 (second edition) 1756 (fi fth edition) 1850 (third edition) 1898 (fourth edition)
1677 (third edition) 1774 (sixth edition) 1856 (reprint) 1900 (Indian and Colonial 
Addendum)
1721 (fourth edition) 1783 (seventh edition) 1901 (Government of India 
Addendum)
1746 (fi fth edition) 1792 (eighth edition) 1914 (fi fth edition)
1788 (sixth edition) 1803 (ninth edition) 1932 (sixth edition)
1809 (seventh edition) 1805 (reprint) 1948 (seventh edition)
1815 (altered edition) 1817 (tenth edition)
1824 (eighth edition) 1839 (eleventh edition)
1836 (ninth edition) 1841 (twelve edition)
1851 (tenth edition) 
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nineteenth century, the ninth in 1803 and the last in 
1841.14 
Th e Dublin Pharmacopoeia had a much shorter ex-
istence. A fi rst specimen edition was distributed only to 
members of the Dublin College of Physicians. A second 
College edition followed before a fi rst public edition 
appeared in 1807. Second and third editions followed, 
with the fi nal reprint of the third edition appearing in 
1856.15 Issues of national identity appear to have played 
a part in the publication of both the Edinburgh and 
Dublin pharmacopoeias; the fi rst edition of the Edin-
burgh Pharmacopoeia preceded the 1707 Acts of Union 
between Scotland and England by eight years; the fi rst 
specimen edition of the Dublin Pharmacopoeia preced-
ed  the Acts of Union (uniting the Kingdoms of Great 
Britain and Ireland in 1801) by the same period.16
As increasing numbers of pharmacopoeias ap-
peared, collections of what were judged to be the most 
useful parts of each were assembled in volumes called 
conspectuses. Th ese were mainly a feature of the early 
nineteenth century. Th ey were usually used abroad as 
the basis of a broader consolidation of pharmacopoeias. 
One of the earliest was published by Robert Graves 
(1763-1849) under the title A Pocket Conspectus of the 
London and Edinburgh Pharmacopoeias in 1797.17
Dispensatories, hospital and military formularies
Th e appearance of pharmacopoeias prompted the pub-
lication of a range of supplementary texts. Individuals 
developed and published guides to the collection and 
making of medicines; these were usually known as dis-
pensatories, although some bore the name pharmaco-
poeia. Th ey were largely a British speciality and were 
essentially pharmacists’ handbooks. Th e Edinburgh 
Dispensatory began life in 1753 when William Lewis 
(c.1708-1781) compiled his New Dispensatory.18 Five 
further editions followed, the last appearing in 1799. 
All editions contained the elements of pharmacy and 
pharmaceutical chemistry in Part 1, gave a detailed de-
scription of materia medica in Part 2 (including the 
medical indications for use of each drug) and composi-
tions in various dosage forms with formulas and direc-
tions in Part 3. 
Th e New Dispensatory was followed by the Edin-
burgh New Dispensatory, the fi rst edition of which was 
published in Edinburgh in 1786. Th e second and third 
editions were edited by Andrew Duncan the elder 
(1744-1828), and the fourth, fi fth and sixth by John 
Rotheram (c. 1750-1804). Th e last of this series ap-
peared in 1801, although it was re-issued in 1818. A 
third series, also called the Edinburgh New Dispensatory, 
fi rst appeared in 1803. All editions were edited by An-
drew Duncan the younger (1773-1832), the twelfth 
and last being published in 1830. Th e success of the 
Edinburgh Dispensatory spawned many others; British 
physicians who took to compiling dispensatories, many 
of which were published abroad, included Th omas 
Fuller (1654-1734), James Shipton (c.1630-1700) and 
Jonathan Goddard (1617-1675).
Beyond the pharmacopoeias, the dispensatories and 
the conspectuses, more specialist needs resulted in a 
range of other publications. Th ese included a range of 
hospital and paupers’ formularies and pharmacopoeias, 
and military and surgical handbooks. However, the only 
British hospital formulary known to have been pub-
lished abroad was that of the Royal Infi rmary of Edin-
burgh, highlighting the reputation of Edinburgh physi-
cians and medical training during this period. Military 
and surgical pharmacopoeias fulfi lled a particular need, 
and several British works on military and surgical phar-
macy were published abroad.19
Th e movement of British pharmaceutical texts 
abroad
Pharmaceutical knowledge travelled across geographi-
cal and national boundaries through a variety of mech-
anisms that all involved the movement of either goods 
or people. Huge numbers of Britons travelled overseas 
to make their fortunes or start new lives. In the seven-
teenth century over 250,000 people emigrated from 
Britain to North America alone. Immigrants included a 
number of physicians and apothecaries, who carried 
with them the publications needed to practice their 
profession. Other publications found their way abroad 
through the normal channels of trade, such as import-
ing by wholesalers. Copies exchanged hands through 
scientifi c interaction; and overseas practitioners ob-
tained copies for their own use. In due course many 
were reprinted or reproduced, with many being used as 
sources of information by those tasked with developing 
similar compilations in their own countries. 
Once received in another country British pharma-
ceutical texts were used in a variety of ways. Th ey could 
be used as received, as an important reference source of 
useful information. Th is was accessible to those familiar 
with Latin, or English where English translations were 
available; they would also be reprinted or reproduced lo-
cally. But in many countries there was inevitably a de-
mand for translations into the local language. Th is could 
be done on a word for word basis, but more often the 
temptation of local translators was to carry out extensive 
edits, with new material added along with local prefer-
ences and prejudices. British pharmaceutical literature 
thus often formed the basis of other countries’ conspec-
tuses and dispensatories, with selections being made 
from a range of foreign pharmacopoeias and formularies.
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British pharmaceutical texts translated or reprinted 
abroad
Outside the English-speaking world there was the a 
substantial demand for translations of British pharma-
ceutical texts. British pharmacopoeias were translated 
into Dutch, German, French, Spanish, Hindustani and 
Malagasy, as well as English and possibly other languag-
es. Th ey were printed in 25 cities in 10 countries, from 
Boston in the United States to Antananarivo in Mada-
gascar. Th e earliest known translation of the London 
Pharmacopoeia was the Pharmacopoeia Collegii Regali 
Londini published in Leyden in the Low Countries 
(Holland and Belgium) in 1677. A second publication, 
attributed to James Shipton, appeared in 1681 follow-
ing publication of a third edition of the London Phar-
macopoeia in 1677. A translation into Dutch was issued 
in Amsterdam in 1696. Cowen notes that, by the time 
the fi rst Edinburgh Pharmacopoeia was reproduced on 
the continent in Gottingen in 1742, at least six issues of 
the London Pharmacopoeia in Latin, English and Dutch 
had already appeared outside Britain.20   
Foreign issues of British pharmacopoeias that have 
been reported in the literature include 47 of the Lon-
don Pharmacopoeia, 27 of the Edinburgh Pharmaco-
poeia and one of the British Pharmacopoeia 1864. Th e 
Dublin Pharmacopoeia was not reproduced abroad ex-
cept as part of other publications.21 Th e number of edi-
tions of British pharmacopoeias published abroad, 
along with the years of their fi rst and last appearance, 
are summarised in Table 2. Together they account for 
94, or 36% of all British pharmaceutical texts pub-
lished abroad. 
Table 2: British pharmacopoeias, conspectuses and hospital and surgical compendia published abroad 1677 to 1871
British text from which edited or translated 
version produced







between fi rst 
and last 
publications




London Pharmacopoeia 1677 1851 174 years 54
Edinburgh Pharmacopoeia 1742 1847 105 years 32
Dublin Pharmacopoeia 1816 1851 35 years 5 
(in Codexes)
British Pharmacopoeia 1868 1885 14 years 3
Total: 94
Conspectuses:
Graves’ Pocket Conspectus 1798 1803 5 years 2
French Conspectus of British Pharmacopoeias 1820 1820 0 years 1
Th omson’s Conspectus 1825 1862 37 years 9
Prescriber’s Pharmacopoeia 1842 1853 11 years 3
Foote’s Practitioner’s Pharmacopoeia 1855 1855 0 years 1
Total: 16
Hospital and pauper compendia:
Edinburgh Hospital Pharmacopoeia 1750 1763 13 years 6
Pharmacopoeia for the Poor (attributed to a Dr W) 1757 1776 19 years 2
Total: 8
Surgical and military compendia:
Th eobald’s Medulla Medicinae Universae 1750 1753 3 years 2
Dossie’s Th eory and Practice of Surgical Pharmacy 1771 1771 0 years 1
Pharmacopoeia Chirurgica 1797 1815 18 years 2
Wilson’s Pharmacopoeia Chirurgica 1818 1818 0 years 1
New Medico-chirurgical Pharmacopoeia 1824 1824 0 years 1
Total: 7
Total for above categories 125
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Th e conspectuses, hospital and pauper compendia and 
surgical and military compendia generally had less im-
pact than the pharmacopoeias and dispensatories. 
However, Th ompson’s Conspectus of the Pharmacopoeias 
of the London, Edinburgh and Dublin Colleges of Physi-
cians, published in 1820, went through seven American 
editions between 1825 and 1862. Later ones included 
American material, which necessitated addition to the 
title of the words ‘and of the United States Pharmaco-
peia’. In Germany, A. Braune added the word ‘Zusätze’ 
to his edition of Th ompson’s work published in 1827.22 
Other works in this category included an anonymous 
Prescriber’s Pharmacopoeia, and John Foote’s Practition-
er’s Pharmacopoeia, which was reproduced in the Unit-
ed States four times between 1842 and 1855.23 
A version of Robert Graves’s A Pocket Conspectus of 
the London and Edinburgh Pharmacopoeias was pub-
lished in Vienna in 1798, under the title Dispensatori-
um Universale, and a faithful reprint appeared in Phila-
delphia in 1803. In Paris a Conspectus des pharmacopées 
de Dublin, d’Edinburg, de Londres et de Paris was pub-
lished in 1820, which included an appendix with mate-
rial taken from seven other pharmacopoeias.24 Anthony 
Th ompson published his Conspectus of the Pharmaco-
poeias of the London, Edinburgh and Dublin Colleges of 
Physicians in 1820. 
Cowen reports fi nding fi ve overseas editions of the 
hospital formulary published by the Royal Infi rmary of 
Edinburgh, including two at Frankfurt (in 1760 and 
1762) and one at Geneva (in 1763). A Pharmacopoeia 
for the Poor was published in Paris in 1757 and again in 
1776; it was claimed to be a translation of a publication 
by a Dr W. of London, although the original has not 
been traced.25 
Of the military and surgical texts, Dossie’s Th eory 
and Practice of Surgical Pharmacy was published in 
French in Paris in 1771. A Spanish version of James 
Wilson’s Pharmacopoeia Chuirurgica, originally written 
in English, was published in 1797 and again in 1815; 
this work was reprinted in Philadelphia in 1818. John 
Th eobald’s military compendium, Medulla Medicinae 
Universae, compiled on the orders of the Duke of Cum-
berland for use at military hospitals abroad, was trans-
lated into Italian in 1750 and French in 1753. Th e 
anonymous English New Medico-chirurgical Pharmaco-
poeia was translated into German, with a note to the 
eff ect that the formulas listed were for handling surgical 
sicknesses.26
Table 3: British dispensatories published abroad 1686 to 1848
British text from which edited or translated version 
produced













Staphorst’s Offi  cina chymica Londinensis 1686 1701 15 years 2
Pharmacopoeia Bateana 1688 1791 103 years 12
Pharmacopoeia Bateana cum Goddard 1702 1776 74 years 14
Lower’s Receipts 1702 1762 60 years 8
Fuller’s  Pharmacopoeia extemporanea 1709 1804 95 years 22
Pharmacopoeia Radcliff eana 1720 1753 33 years 5
Quincy’s Pharmacopoeia offi  cinalis et extemporanea 1749 1785 36 years 3
Fuller’s Pharmacopoeia Domestica 1750 1753 3 years 3
James’s Pharmacopoeia Universalis 1758 1758 0 years 1
Pharmacopoeia  Meadiana 1761 1785 24 years 5
Brookes General Dispensatory 1765 1773 8 years 6
Lewis’s New Dispensatory 1768 1815 47 years 21
Edinburgh New Dispensatory (Duncan Sr) 1791 1798 7 years 2
Munro’s Treatise and Translation of the London 
Pharmacopoeia
1791 1797 6 years 6
Pearson’s Th esaurus Medicaminum 1793 1800 7 years 2
Edinburgh New Dispensatory (Rotheram) 1796 1797 1 year 5
Edinburgh New Dispensatory (Duncan Jr) 1805 1850 45 years 17
Christison’s Dispensatory 1848 1848 0 years 1
Total: 135
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Authorship of British pharmaceutical texts pub-
lished abroad
A wide range of individuals was involved in producing 
or translating British pharmaceutical texts. Th e largest 
single group of texts published abroad was the dispen-
satories, although not always under that title. Table 3 
summarises the number of editions published, with the 
years of their fi rst and last appearance. Together they 
account for 135, or 52% of all such texts published 
abroad. Shipton’s Pharmacopoeia Bateana was pub-
lished in Amsterdam in 1688. During the eighteenth 
century 26 versions were published in 10 cities, in Hol-
land, Belgium, Switzerland, Italy, France, Spain and 
Portugal. It mainly appeared in Latin, although Dutch 
and Portuguese translations are known. An overseas 
version of the dispensatory of Jonathan Goddard was 
published in Frankfurt in 1702, under the title Arcana 
Goddardiana; this was the fi rst of at least 13 versions. 
Th omas Fuller’s Pharmacopoeia Extemporanea ap-
peared on the continent soon after Bate’s, in 1709. 
Many versions of the Pharmacopoeia Bateana included 
an appendix written by Fuller; around 21 versions were 
published during the eighteenth century. When it last 
appeared, in 1804, it had been published in eight cities 
in Holland, Belgium, France, Switzerland and Italy. 
Fuller’s later volume, the Pharmacopoeia Domestica, ap-
peared around 1750 in Leyden, and possibly also in 
Basel and Louvain. Th e pharmaceutical texts that 
spread around Europe during this period were thus 
largely the work of four Britons; Bate, Shipton, Godd-
ard and Fuller. 
But several other dispensatories by lesser known au-
thors also became popular. Th ese included works by 
Nicholas Staphorst, Richard Lower, John Radcliff e and 
Robert James. Th ey variously appeared in Latin, Ger-
man, French, Italian or Portuguese. Cowen found 31 
references to such authors, the fi rst in 1686, the last in 
1800.27 Th e most popular of the dispensatories was the 
Edinburgh New Dispensatory; between 1768 and 1850 
six American and 18 European versions were published. 
It was considered to be the ‘most esteemed’ of British 
pharmaceutical literature, with versions appearing in 
German, French, Dutch, Italian and Portuguese. Th ey 
were large publications; the French edition of 1775 ap-
peared in three volumes. 
Whilst most of the translations were carried out by 
local physicians or pharmacists, some were undertaken 
by British physicians who had emigrated to the country 
concerned. In Russia, Sir Alexander Crichton (1763-
1856), an Edinburgh trained physician, was the co-au-
thor of the Pharmacopoeia in usum nosocomii pauperum 
Petropolitani, published at St Petersburg in 1807.28 In 
Prussia, Sir James Wylie (1768-1854), a physician from 
Aberdeen, acknowledged the infl uence of the London 
and Edinburgh pharmacopoeias, as well as the Prussian 
pharmacopoeia, in the compilation of his Pharmaco-
poeia Castrensis Ruthena, published in 1808.29 Some 
years later, in 1862, Andrew Davidson went out to 
Madagascar to be physician to King Radama II. In 
1871 he presented a version of the British Pharmaco-
poeia in the Malagasy language, the British Faramako-
pia. Its stated aim was to disseminate pharmaceutical 
knowledge amongst local practitioners.30
Th e rise and fall of British pharmaceutical texts pub-
lished in Europe
Year by year examination of Cowen’s tables31 enables 
an assessment to be made of the extent and rate of up-
take of British pharmaceutical texts in each country. 
Th e quarter century of publication of the 260 volumes 
identifi ed by Cowen is indicated in Table 4. Th is indi-
cates a steady rise in publications up to the mid eight-
eenth century, and a steady decline thereafter. But a 
quarterly analysis disguises large year to year variations 
and extended periods when no British pharmaceutical 
texts at all were published abroad. Th is sudden rise and 
fall in their popularity can be at least partly explained 
by geopolitical events; for much of the period Euro-
pean nations were at war with either Britain or each 
other. 
It was almost 60 years after its fi rst appearance in 
Britain that the Dutch translation of the London Phar-
macopoeia was published 1677. Its second edition had 
been published in 1650, and its third in 1677. Th e 
Dutch appear to have been in no hurry to make use of 
the London publication. Part of the explanation may 
be that until 1674 England and the Netherlands were 
regularly at war.32 Dutch translations of British texts 
rose steadily following the assumption of the British 
crown by the Dutch William of Orange and his wife 
Mary in 1688. Th e production of such translations 
peaked in the 1770s, with seventeen appearing between 
1751 and 1775. Th ey then declined, at a time when 
they were still rising in Germany, Italy and elsewhere. 
Geopolitical events may again provide some explana-
tion for this sudden loss of popularity of British texts. 
Th e Fourth Anglo-Dutch War broke out in 1780, and 
continued until 1784. Britain was clearly out of favour 
in the Low Countries, although seven pharmaceutical 
texts were published there between 1776 and 1800 nev-
ertheless. 
France, Britain’s closest neighbour, initially 
showed little interest in British pharmaceutical texts; 
the earliest British text published there was the Phar-
macopoeia Bateana in 1704, 27 years after adoption of 
the fi rst British text in the Netherlands, and some 
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years after Germany (1686), Switzerland (1693) and 
Italy (1703). France had a tradition of producing its 
own pharmaceutical literature, such as the works of 
Charas, Lémery, Pomet and Manget;33 and England 
and France were almost continuously at war, from the 
Hundred Years War to the Anglo-French War between 
1627 and 1629. Relations between the countries re-
mained troubled throughout the seventeenth century 
and for much of the eighteenth century. But the Seven 
Years’ War, starting in 1754, soon engulfed most of 
Europe. At its end Britain was soon at war with France 
again. An Anglo-French War took place between 1778 
and 1783, and in 1779 Britain was also at war with 
Spain. Th e French Revolution in 1789 caused further 
disruption. Any peace in Europe was broken by the 
start of the Napoleonic Wars in 1799, continuing un-
til 1815.
But wars and blockades rarely put a stop to the 
translation and publication of British pharmaceutical 
texts aboard. Editions of the London Pharmacopoeia ap-
peared in France in 1761, 1762, 1764 and again in 
1788, throughout both the Seven Years’ War and the 
Anglo-French War. Th e Napoleonic Wars brought 
things to a temporary halt; but the London Pharmaco-
poeia of 1809 was translated into French by Chaussier, 
and it appeared in Paris as La Pharmacopée du Collège de 
Médecine de Londres in 1812 on the very eve of Napo-
leon’s defeat in Europe.34 Further French editions ap-
peared in 1837 and 1840. In Paris the American physi-
cian William Tazewell included a pharmacopoeia in the 
second part of his Vade Mecum Medicum. He acknowl-
edged that this was developed from his notes as a stu-
dent at Edinburgh, and from other sources including 
the London Pharmacopoeia. 
Th e period between 1776 and 1800 saw the rapid 
uptake of British pharmaceutical texts by Germany. 
Pre-French Revolution publications appearing in Ger-
many showed a strong preference for dispensatories and 
hospital and military compendia. An edition of Quin-
cy’s Pharmacopoeia Offi  cinalis appeared in 1749, a 
Th eobald’s Medulla Medicinae in 1753, a Pharmaco-
poeia for the Poor in 1757 and a Fuller’s Pharmacopoeia 
Extemporanea in 1785. Th ere is a noticeable preference 
by Germany for British rather than French texts after 
the Napoleonic Wars, although a German translation 
of a French Conspectus of British Pharmacopoeias ap-
peared in 1820. Post-revolution publications in Ger-
many included Lewis’s New Dispensatory in 1803, and 
an Edinburgh Dispensatory edited by Andrew Duncan 
junior in 1826.
In Italy 32 editions of British pharmaceutical texts 
were published over 150 years. Th e fi rst (a Pharmaco-
poeia Bateana cum Goddard) was published in 1703, 
the last (an Edinburgh Dispensatory) in 1850. But in 
other European countries the infl uence of British texts 
was more limited. Although one of the fi rst countries to 
do so Switzerland published only eight British texts be-
tween 1683 (a Pharmacopoeia Bateana) and 1766 (an 
Edinburgh Pharmacopoeia). Portugal published seven 
editions, from a Pharmacopoeia Bateana in 1713 to sev-
eral versions of Lewis’s New Dispensatory  in 1815. 
Spain published just three editions, a version of the 
London Pharmacopoeia in 1797 and editions of the 
Pharmacopoeia Chirurgica in 1797 and again in 1815. 
Finally, Austria published two British pharmaceutical 
texts; a version of the Edinburgh Pharmacopoeia ap-
peared in 1778, and one of Graves’s Pocket Conspectus 
appeared in 1798.




















Germany 1 17 9 25 32 16 5 2 107
Netherlands 5 8 8 17 7 1 46
Italy 2 3 9 10 4 4 32
France 2 1 12 4 3 5 27
Switzerland 1 3 4 8
Portugal 1 2 1 3 7
Spain 1 2 1 4
USA 1 4 5 7 5 22
Austria 2 2
India 1 2 1 4
Madagascar 1 1
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Th e infl uence of British pharmaceutical texts be-
yond Europe
British pharmaceutical texts found their way not only 
to Europe but to all those places where Britain estab-
lished colonies or acquired territories as part of its 
growing empire; these included America and India. Be-
fore they developed their own, medical and pharma-
ceutical practitioners in America relied heavily on the 
European books they took with them. Most American-
born physicians trained at either Edinburgh or London 
and returned with the latest British pharmaceutical lit-
erature. Th is usually included the Edinburgh and Lon-
don dispensatories and pharmacopoeias, although the 
Parisian Pharmacopoeia was sometimes included. Prac-
titioners from other countries used the literature of 
their own country, although English pharmaceutical 
texts remained dominant.35 
An edition of the London Pharmacopoeia was pub-
lished in America in 1720, but enthusiasm for reprint-
ing British texts was interrupted by the American War 
of Independence (the American Revolutionary War) 
between 1775 and 1783. However, the infl uence of 
such texts on American practice actually increased after 
the war. Various editions of the Edinburgh Dispensatory 
were published in 1791, 1796, 1798 and 1805; and a 
faithful reprint of Robert Graves’ A Pocket Conspectus of 
the London and Edinburgh Pharmacopoeias appeared in 
Philadelphia in 1803.
Th e infl uence of both the London and Edinburgh 
pharmacopoeias is apparent in the compilation of the 
fi rst Pharmacopoeia of the United States of America.36 
Preparation began in 1817 and it was published in 
1820 in Boston.37 An American edition of Wilson’s 
Pharmacopoeia Chirurgica appeared in 1818 along with 
a new edition of the Edinburgh Dispensatory, and one of 
Th omson’s Conspectus was published in 1825. A further 
12 British pharmaceutical texts were printed in the 
United States between 1842 and 1862, the last two be-
ing revised editions of Th omson’s Conspectus. None ap-
peared after the end of the American Civil War in 1865.
British pharmaceutical texts including the London 
and Edinburgh pharmacopoeias were also taken to In-
dia by those who went there to serve the nation or set 
up businesses in the early nineteenth century. But the 
need for texts that met the particular needs of practi-
tioners in India was soon recognised, and the result was 
the publication of a Bengal Dispensatory in 1841 and of 
a Bengal Pharmacopoeia in 1844; these were strongly 
infl uenced by the Edinburgh New Dispensatory and the 
Edinburgh Pharmacopoeia.38 Following the Indian Mu-
tiny of 1857 (India’s First War of Independence) and 
the start of the British Raj, British-produced texts came 
to dominate, particularly with publication of the fi rst 
edition of the British Pharmacopoeia in 1864.39 Its 
sphere of infl uence slowly widened with each successive 
edition. In 1885 the locally produced Pharmacopoeia of 
India of 1868 was suppressed and the British Pharma-
copoeia was made the ‘sole authority on all matters per-
taining to pharmacy in India, and remained an impor-
tant infl uence on Indian pharmaceutical literature 
thereafter’.40 But British texts did not have a monopoly 
on useful information in India; American texts also 
found a use.41
Figure 1: Number of British pharmaceutical texts published abroad by decade 1670s to 1880s
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An overview of the rise and fall in the popularity of 
British pharmaceutical texts can be obtained by collat-
ing the number of texts published abroad during each 
decade (Figure 1). Th is shows an initially small rise in 
the number of publications in the 1700s, which dips 
slightly during the 1720s and 1730s, before rising to a 
peak of 31 publications during the 1780s. Th ere is then 
a gradual decline towards the 1830s, with another 
short-lived jump to 16 in the 1840s. Th ereafter the 
number of publications declines rapidly to only one in 
the 1880s. Th is analysis indicates that a total of 130 pub-
lications, or 50% of the total, appeared during the 
50 year period between 1750 and 1799. By the start of 
the nineteenth century interest in British pharmaceuti-
cal texts had dropped considerably, and by the time the 
fi rst British Pharmacopoeia was published in 1864 it 
had virtually ended.
Th e reception of British pharmaceutical texts abroad
Sources shedding light on how British pharmaceutical 
texts and translations of them were received abroad in-
clude the introductory comments made by translators 
and editors and contemporary book reviews. From 
these it is possible to discern the main factors account-
ing for the ready acceptance of British pharmaceutical 
texts abroad, the enthusiasm with which they were re-
ceived, and the infl uence they had on local practice. 
Cowen identifi ed three such factors: it took place with-
in the normal processes of cultural diff usion; the intrin-
sic quality of the British product was such that people 
valued its contents; and there was a clear need that was 
not adequately met locally.42 
Not surprisingly, editors and translators preparing 
their own editions and translations tended to see par-
ticular merit in the British works they selected, and this 
was often readily recognised by those who reviewed the 
new volumes. British works were widely acknowledged 
for ‘their enlightened approach’; ‘their great discern-
ment’; and ‘their rejection of tradition in favour of expe-
rience’.43 Th e simplicity and brevity of British works 
were also much praised. Th ey were also extolled for their 
layout and ‘neat arrangement’. Conspectuses, combin-
ing material from several pharmacopoeias, were consid-
ered especially useful. Th e fact that the works were ‘the 
result of eff orts of distinguished physicians and collec-
tive eff orts of Colleges’ added to their prestige. 
Th e process of translation was usually accompanied 
by varying degrees of editing, correcting and augmenta-
tion. Sometimes it was claimed that the translation re-
sulted in a vast improvement to the original. Some crit-
ics even contended that the only merit of the British 
works came from the local editors. Th e French version 
of the London Pharmacopoeia published in Paris in 
1761, and again in 1771, had, according to one critic at 
the time, merely used the London Pharmacopoeia as a 
rough draft. It was criticised as being simply a hand-
book ‘without theory and without principle’ on the ba-
sis of which the French translator had succeeded in 
creating an outstanding work.44 Even when pharmaco-
poeias were adopted largely unchanged the local com-
mentary was sometimes highly critical. A later Paris 
printing of the London Pharmacopoeia in 1785 was 
criticised for being little diff erent to that of an edition 
that had appeared in 1766.45 
Th e most serious criticisms came from Germany, 
although this was largely limited to the London Phar-
macopoeia, particularly that of 1788.46 An anonymous 
work published in Hamburg in 1790 was picked up by 
many learned journals. It contended that the London 
Pharmacopoeia did not merit the great praise that had 
been heaped upon it, a view echoed by Chemische An-
nalen, which claimed to have held such an opinion for 
some time.47 Amongst the defi ciencies found were that 
some descriptions were too short, nomenclature had 
been changed, effi  cacy, strength and dosage were miss-
ing and many important preparations had been omit-
ted.48 But such criticisms were the exception rather 
than the rule; the overwhelming majority of reviews 
indicated that British pharmaceutical texts were very 
favourably received on the continent.49  
Th e compilers of the fi rst American pharmacopoeia 
in 1820 also were not uncritical of the British texts. Th e 
preface to this volume notes that ‘the fault of the lists of 
the materia medica which have been adopted in diff er-
ent countries has always been their redundancy rather 
than their defi ciency. Th e number of articles necessary 
for the management of diseases ... is always very far 
short of the catalogue aff orded by most pharmacopoe-
ias.’ As a consequence ‘many articles contained in Euro-
pean books have been omitted in the American Phar-
macopoeia.’50
Th e continuing popularity of British pharmaceuti-
cal texts abroad  
Whilst some translations and reprints abroad survived 
only a single edition, many others went through nu-
merous editions and some continued to be published 
for over a 100 years. It is also evident that some contin-
ued in use for many years after the last edition ap-
peared. Clearly it was highly profi table to reproduce 
such literature abroad, since it would not have contin-
ued for as long as it did otherwise. Th e investment in 
time and eff ort involved in translating British pharma-
ceutical texts was repaid many times. Profi tability was a 
consequence of both recognition and acceptance, and it 
was the key to explaining the continuing popularity of 
British texts abroad. 
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It was the willingness of the British compilers of 
pharmaceutical texts to tackle irrationality and to em-
brace new discoveries that set them apart from their 
counterparts elsewhere. Indeed, by the late eighteenth 
century the pharmacopoeias were said by some to have 
been developed in Britain with ‘a reforming zeal’51 that 
eliminated ‘superfl uities’,52 and the compilers were 
praised for having the courage to erase ‘even the name 
of Th eriac’.53 But others were alarmed at the excessive 
number of eliminations. Time and again, noted Cow-
en, the continental editors added long lists of drugs that 
had been omitted from the British publications. Th e 
French pharmacist C.O. Cadet, refl ecting on the tenth 
edition of the London Pharmacopoeia published in 
1809, wrote in 1812 that ‘perhaps the reforming zeal of 
the English doctors has gone a little far’.54 Nevertheless, 
new medical knowledge and new medicines were incor-
porated into the translations and reprints, the new 
chemistry was taken into account and the new nomen-
clature of Linnaeus was introduced. 
Cowen concluded that the popularity of British 
pharmacopoeial literature abroad refl ected Britain’s 
reputation for clear leadership in pharmacopoeial re-
form over many years, dating from compilation of the 
fi rst edition of the London Pharmacopoeia by the Royal 
College of Physicians early in the seventeenth century.55 
Later key fi gures in British pharmacopoeial reform, in-
cluding Sir Hans Sloane and Sir John Pringle, acceler-
ated this approach by deleting many irrational items 
from subsequent editions and adding new items based 
on contemporary practice. But many others were also 
involved in pressing for reform, including Lewis in de-
veloping his New Dispensatory and the others who de-
veloped their own compilations.
Th e decline in popularity of British pharmaceutical 
texts abroad  
Th e popularity of British pharmaceutical texts abroad 
slowly began to decline from the early nineteenth cen-
tury. Several developments took place largely in paral-
lel; in Britain the range of texts broadened in response 
to developments in science, especially the transforma-
tion of pharmaceutical chemistry in the early 1800s, 
leading to advances in the analysis, synthesis and test-
ing of drugs. Th is facilitated a more scientifi c approach 
to materia medica that was refl ected in new texts. In 
1839 Jonathan Pereira, who was appointed professor of 
materia medica at the Pharmaceutical Society of Great 
Britain right after it was founded in 1841, published 
his Elements of Materia Medica in two volumes; this was 
claimed as the fi rst great English work on materia med-
ica, and in its time was stated to be without rival in any 
other language.56
Other development took place elsewhere. By the 
early nineteenth century many of the countries where 
British pharmaceutical texts were popular had produced 
texts of their own, including pharmacopoeias that in-
creasingly applied nationally rather than at the city state 
or province level.57 Th ompson describes the origins and 
development of no fewer than 35 national pharmaco-
poeias.58 In France, for example, the fi rst Codex Medica-
mentarius sive Pharmacopoea Gallica was published in 
Latin in 1818, and was translated into French a year 
later. Editions of the Codex were published regularly, in 
1837, 1866, 1884, with a supplement in 1895, and 
then at regular intervals during the twentieth century.59 
As they introduced and refi ned their own works, usu-
ally in their own language, countries became less de-
pendent on works published elsewhere.
Th e second half of the century was a time of rapid 
growth of pharmaceutical knowledge, and new texts 
emerged to explain and interpret it. In 1859 Peter 
Squire published the fi rst edition of his Companion to 
the British Pharmacopoeia; it ran to 19 editions, the last 
appearing in 1916. International collaborations be-
came more frequent; one such resulted in the publica-
tion in 1874 of Pharmacographia by the German Frie-
drich Flückiger and the British Daniel Hanbury; this 
remained an authoritative text on the history, com-
merce and science of drugs for many years.60  Th e Extra 
Pharmacopoeia, which became a two volume survey of 
information not provided in the British Pharmacopoeia, 
was fi rst published by William Martindale and W. 
Wynn Westcott in 1883.  It continues to be published 
as Martindale: Th e Complete Drug Reference.61
Th e second half of the century also saw major devel-
opments in pharmaceutical technology, as well as the 
introduction of new drugs; patents were taken out on a 
vast range of equipment for the making and adminis-
tration of medicines. Indeed, the period between 1830 
and 1890 has been described as ‘the golden age of phar-
maceutical invention’.62 In Britain offi  cial texts often 
struggled to keep up. Burroughs Wellcome registered 
the trade name ‘Tabloid’ in 1884 for their brand of 
compressed pill; the British Pharmacopoeia of 1898 
contained the formula for only one tablet, nitroglyerin 
tablets, which in any case was made by moulding rather 
than compression.63
Th e fall in popularity of British texts coincided with 
a growth in European imperialism and increasing com-
petition between European powers. Th e expansion of 
the British Empire saw a shift away from translations of 
pharmaceutical texts appearing on the continent to 
their use unaltered in the territories of the empire.64 
Pharmacopoeias became not only important symbols 
of nationalism but also sometimes served other pur-
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poses, such as instruments of imperialism.65 But it soon 
became clear that pharmacopoeias developed in tem-
perate zones could not be always be imposed unmodi-
fi ed in tropical zones; in 1900 an Indian and Colonial 
Addendum to the fourth edition of the British Pharma-
copoeia of 1898 was published. It was swiftly followed 
by a Government of India edition of the addendum in 
l901. By the time of the fi fth edition in 1914 the Gen-
eral Medical Council felt able ‘to produce a British 
Pharmacopoeia suitable for the whole Empire.’66
In 1845 Jonathan Pereira emphasised the shifting 
geographical focus of British pharmaceutical interest in 
restating the claim for British leadership in pharmaco-
poeial reform. He declared that 
‘no country in the world possesses so many facilities 
for carrying on inquiries such as those to which I 
here allude, as Great Britain. Her numerous and 
important colonies in all parts of the world, and her 
extensive commercial relations, particularly fi t her 
for taking the lead in investigations of this kind. 
Moreover, she is peculiarly interested in such in-
quires. From her extensive possessions in diff erent 
parts of the world, we draw a very large portion of 
the substances now used in medicine’.67
Conclusion
Th is paper has presented further analysis of Cowen’s 
study of the popularity of translations and edited ver-
sions of British pharmaceutical texts abroad, from the 
late seventeenth to the late nineteenth centuries. It is 
clear from this analysis that a wide range of pharmaceu-
tical texts were translated or reprinted, with newer edi-
tions being translated or reprinted following their pub-
lication in Britain. At least 260 translations or 
re-printings of some 30 such publications were pro-
duced. Th e largest number of translations was made of 
the London Pharmacopoeia; there were 54, representing 
over 20% of the total. But the largest category of pub-
lications translated were the dispensatories; there were 
135, representing 52% of the total.
Reprints and translations of British pharmaceutical 
texts were not evenly distributed around Europe and 
elsewhere. Germany was by far the most enthusiastic 
translator and re-printer of such texts, accounting for 
107 or 41% of the total, despite the fact that it ac-
counted for some of the strongest criticisms. Germany 
was followed by the Netherlands with 46, Italy with 32, 
France with 27 and the United States with 22. Together 
these countries accounted for 234 or 90% of the total. 
In other countries British pharmaceutical texts had 
only very limited popularity. It is likely that this pattern 
of distribution is refl ected in the wider medical litera-
ture of the time.
Th ere was often a considerable time lag between 
fi rst publication in Britain and the appearance of the 
fi rst translation abroad, although this varied greatly 
over the decades. Although there are likely to be several 
reasons for this it seems that geo-political events such as 
wars played an important part. Reprinting often re-
commenced after the return of peace. Th e popularity of 
such texts was not evenly distributed across the seven-
teenth and eighteenth centuries but fl uctuated consid-
erably. It increased slowly in the early part of the eight-
eenth century and reached a peak between 1750 and 
1800, during which period 132, or around 51%, of 
these publications appeared.
British pharmaceutical texts experienced a diff erent 
kind of popularity in the late twentieth century. In the 
post-colonial world many former British colonies chose 
to adopt the British Pharmacopoeia. Today, standards 
and specifi cations laid down in the British Pharmaco-
poeia have been adopted in over 100 countries.68 Brit-
ain too found a new use for its pharmacopoeia, as an 
instrument of economic development and assistance to 
developing countries and to Eastern Europe; it was a 
means of helping their regulatory authorities police 
markets in counterfeit drugs.69 British pharmaceutical 
texts thus continue to have signifi cant infl uence abroad 
even in the twenty-fi rst century.
Author’s address: Stuart Anderson, Emeritus Pro-
fessor of Pharmacy History, Centre for History in Pub-
lic Health, London School of Hygiene & Tropical 
Medicine, 15-17 Tavistock Place, London WC1H 9SH.
Email: Stuarrt.Anderson@lshtm.ac.uk
Endnotes and References
1. Cowen, DL. Pharmacopoeias and Related Literature in 
Britain and America, 1618 to 1847. Aldershot: Ashgate Vario-
rum, 2001.
2. Matthews, LG. History of Pharmacy in Britain. London: 
E. & S. Livingstone Ltd, 1962, 74-81.
3. Th ompson, CJS. Th e Mystery and Art of the Apothecary. 
London: John Lane the Bodley Head Ltd, 1929, 141.
4. Cowen, DL. (Note 1) 2001: 87.  
5. Cowen, D.L. Th e Edinburgh Pharmacopoeia. In Ander-
son, RGW and Simpson ADC. (eds.) Th e Early Years of the Edin-
burgh Medical School. Edinburgh: Royal Scottish Museum, 1976, 
1-20. 
6. Matthews, LG. (Note 2) 1962: 90.  
7. Th ompson, CJS. (Note 3) 1929: 142-43.
8. Grier, J. Th e Pharmacopoeia. In A History of Pharmacy. 
London: Th e Pharmaceutical Press, 1937, 143.
9. Wootton, AC. Chronicles of Pharmacy. Volume 2. Lon-
don: MacMillan and Co. Ltd, 1910, 68.
10. Ibid., 68.
11. Ibid., 65.
12. For fuller accounts of British pharmacopoeias see also 
Cowen, DL. Th e Edinburgh Pharmacopoeia. Medical History. 
1957; 1(2): 123-139. Grier, J. Th e Pharmacopoeia. In A History 
https://doi.org/10.24355/dbbs.084-202007291100-0
32 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/2
of Pharmacy, London: Th e Pharmaceutical Press, 1937, 140-162. 
Matthews, LG. Chemical Medicines, Formularies and Pharma-
copoeias. In History of Pharmacy in Britain, Edinburgh and Lon-
don: E. & S. Livingstone Limited, 1962, 61-111.
13. Matthews, LG. (Note 2) 1962: 82.  
14. Cowen, DL. Th e Edinburgh Pharmacopoeia. Medical 
History. 1957; 1: 123-139 and 340-353.
15. Anderson, SC. Pharmacopoeias of Great Britain. In A 
History of the Pharmacopoeias of the World. Berlin, Germany: In-
ternational Society for the History of Pharmacy. 2013: 1-8. 
http://www.histpharm.org/ISHPWG%20UK.pdf. Accessed 28 
February 2017.
16. For an account of the role of national identity in the 
development of the London, Edinburgh and Dublin pharmaco-
poeias see Anderson, SC. National identities, medical politics 
and local traditions: Th e London, Edinburgh and Dublin Phar-
macopoeias 1618 to 1807. In Gabriel, J. and Crawford, M. (eds.) 
Organizing the World of Healing Goods: Materia Medica, Pharma-
copoeias, and the Codifi cation of Th erapeutic Knowledge in the 
Early Modern World (forthcoming).
17. Graves, R. A Pocket Conspectus of the London and Edin-
burgh Pharmacopoeias. First edition. London: J. Murray and S. 
Highley, 1797. 
18. Cowen, DL. Th e Edinburgh Dispensatories. Papers of 
the American Bibliographical Society, Columbia, South Carolina, 
1951, 45; 3-14.
19. Cowen, DL. (Note 1) 2001: 89.
20. Ibid., 87-88.
21. Cowen, DL. (Note 1) 2001: 87.
22. Cited in Cowen, DL. (Note 1) 2001: 90, ref. 57.
23. Full bibliographic details for each of the publications 
referred to can be found in Cowen, DL. (Note 1) 2001: 105-135. 
24. Cited in Cowen, DL. (Note 1) 2001: 90, ref. 56.
25. Cowen, DL. (Note 1) 2001: 89.
26. Ibid., 90.
27. Cowen, DL. (Note 1) 2001: 89.
28. Ibid., 2001: 85. 
29. Berman, A. Early Russian Military and Naval Formular-
ies 1765 to 1840. American Journal of Hospital Pharmacy. 1960; 
17: 218 and n.7: 216.  
30. Cowen, DL. (Note 1) 2001: 86.
31. Cohen, DL. British Pharmacopoeial and Related Litera-
ture published abroad arranged by year and country of publica-
tion. In Cowen, DL. (Note 1) 2001: 171-183. 
32. Th e First Anglo-Dutch War took place between 1652-54, 
the Second between 1665-67, and the Th ird between 1672-74.
33. Lafont, O. A stroll through the collections of pharmaco-
poeias of the Order of Pharmacists in Paris. In A History of the 
Pharmacopoeias of the World. Berlin, Germany: International So-
ciety for the History of Pharmacy. 2013: 1-10. http://www.histp-
harm.org/ISHPWG%20France.pdf. Accessed 28 February 2017.
34. Ibid., 2001: 96.
35. Sonnedecker, G. Books Imported from Europe. In Kre-
mers and Urdang’s History of Pharmacy, Fourth edition. Madison, 
Wisc: American Institute of the History of Pharmacy, 1976: 255. 
36. Th e Pharmacopoeia of the United States of America 1820, 
Boston, Mass: By the Authority of the Medical Societies and Col-
leges, 1820: 22.
37. Ibid., 24.
38. Singh, H. Pharmacopoeias and Formularies: History of 
Pharmacy in India and Related Aspects, Volume 1. Delhi: 
Vallabh Prakashan, 1994; 30-34.   
39. Dunlop, DM. and Denston, TC. Th e History and De-
velopment of the British Pharmacopoeia.  British Medical Jour-
nal. 1958; 2(5107): 1250-1252.
40. Singh, H. Pharmacopoeias and Formularies: History of 
Pharmacy in India and Related Aspects, Volume 1. Delhi: 
Vallabh Prakashan, 1994; 62.   
41. Anderson, SC. Travellers, Patent Medicines and Phar-
macopoeias: American Pharmacy and British India 1857 to 
1931, Pharmacy in History 2016; 58(3+4): 63-82.
42. Cowen, DL. (Note 1) 2001: 92.
43. Londner Apothekerbuch. Oberdeutsche allgemeine Lit-
eraturzeitung von Jahre. 1790: 451-2. Cited in Cowen, DL. 
(Note 1) 2001: 22. 
44. Journal Encyclopedique, 1773; II, Pt.3: 425. Cited in 
Cowen, DL. (Note 1) 2001: 101.
45. Ibid., 95.
46. Scherer, ANA. Litteratura pharmacopoearum collecta. 
Leipzig. 1822: 473. Cited in Cowen, DL. (Note 1) 2001: 101.
47. Chemische Annalen, 1791; 1: 49. Cited in Cowen, DL. 
(Note 1) 2001: 101.
48. Allgemeine deutsche Bibliothek, 1791; 98: 397-398. Cited 
in Cowen, DL. (Note 1) 2001: 101.
49. Cowen, DL. (Note 1) 2001: 96.
50. Th e Pharmacopoeia of the United States of America 1820. 
(Note 33) 1820: 20. 
51. Cited in Cowen, DL. (Note 1) 2001: 93, ref 83.
52. Cited in Cowen, DL. (Note 1) 2001: 93, ref 84.
53. Cowen, DL. (Note 1) 2001:93-94.
54. Cadet, C.O. Bulletin de Pharmacie. 1813; 5: 331.
55. Cowen, DL. (Note 1) 2001: 94.
56. Grier, J. (Note 8) 1937: 146. 
57. For brief accounts of the development of pharmacopoe-
ias in over 20 states or countries see the website of the Working 
Group on the History of Pharmacopoeias of the International 
Society for the History of Pharmacy. Available at http://www.
histpharm.org/ISHPWG.htm.
58. Th ompson, CJS. The Mystery and Art of the Apothecary. 
London: John Lane, Th e Bodley Head Ltd, 1929: 286.
59. Lafont, O. (ed.) A stroll through the collections of Pharma-
copoeias of the Order of Pharmacists in Paris. Working Group on 
the History of Pharmacopoeias, International Society for the 
History of Pharmacy. http://www.histpharm.org/ISHPWG%20
France.pdf. Accessed 07/02/17.
60. Ibid., 152.
61. For details of the thirty-eighth edition of Martindale: 
Th e Complete Drug Reference see http://www.pharmpress.com/
product/9780857111395/martindale38.
62. Anderson, SC. Th e Golden Age of Pharmaceutical Inven-
tion 1830 to 1890. Pharmacy History Australia. 2003: 220, 5-7.
63. Trease, GE. Pharmacy in History. London: Bailliere, Tin-
dall and Cox. 1964: 236. 
64. Anderson, SC. Pharmacy and Empire: Th e British Phar-
macopoeia as an Instrument of imperialism 1864 to 1932. Phar-
macy in History, Special  Issue. 2010: 52(3&4), 112-121. 
65. Ibid., 116. 
66. Preface to the British Pharmacopoeia. Fifth Edition. 
London: Th e General Medical Council. 1914: ix.
67. Pereira, J. Quoted in Historical Sketch of the Progress of 
Pharmacy in Great Britain, Bell, J. and Redwood, T. London: 
Pharmaceutical Society of Great Britain. 1880: 171.  
68. Cartwright, AC. Th e British Pharmacopoeia, 1864 to 
2014: Medicines, International Standards and the State. Farnham, 
Surrey: Ashgate, 2014.
69. Cunningham, R. Consultation on the Future of the British 
Pharmacopoeia and British Pharmacopoeia Veterinary, London: 
Department of Health (Th e Cunningham Report). Quoted in 
Cartwright, AC. (Note 50). 1999: 116-7. 
https://doi.org/10.24355/dbbs.084-202007291100-0
Figure 1. Portrait of Sir Walter Raleigh (c.1552-1618)
(from Raleigh 1614, Wellcome Library, London)
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Establishing the provenance of a medicine 
chest belonging to Sir Walter Raleigh 
(c.1552-1618)
Christopher J. Duffi  n
Abstract
Sir Walter Raleigh, the Tudor explorer and adventurer, 
was arrested for treason by James I following the death 
of Queen Elizabeth I in 1603. A stay of execution was 
granted and he was sent to the Tower of London. Th ere 
he was able to undertake scientifi c investigations. He 
owned a small medicine chest, and this may have been 
with him in the Tower. Th e chest survives and is on dis-
play in a Lisbon museum. Th is paper presents a descrip-
tion of the chest and its possible use, and discusses the 
evidence for establishing its provenance. It is concluded 
that its origin and initial ownership are beyond doubt.
Introduction
Sir Walter Raleigh (sometimes spelt Rawleigh or 
Ralegh) is probably one of the best known characters of 
Tudor Britain (Figure 1). His date of birth is uncertain 
but is variously reported as between 1552 and 1554; he 
died in 1618. He has been the subject of many biogra-
phies.1 He led a rich life as, amongst other things, a 
soldier, captain, sea captain, courtier, poet, ship design-
er, empire builder, explorer, historian, author, naval and 
military strategist, parliamentarian and chemist. Clear-
ly a multi-talented polymath, his scientifi c work has so 
far received very little attention in the literature.
Falling in and out of favour with Queen Elizabeth I, 
shortly after her death in March 1603 he was arrested 
for treason against her successor, James I, in respect of 
his supposed involvement in the Main Plot. Placed on 
trial at Winchester on 17 November 1603, Raleigh was 
given the death sentence. James granted a stay of execu-
tion, however, but fell short of mitigating the full pen-
alty, as later became clear at Raleigh’s second trial 
(28 October 1618). In respect of the King’s mercy, Ra-
leigh was taken to the Tower of London on 16 Decem-
ber 1603. 
After several months of extreme concern over his 
eventual fate, Raleigh began to occupy his mind with 
study.  It might seem incredible today that conditions 
were such as to permit his engaging in active research, 
but he was given considerable freedom of movement 
and action by the then Lieutenant of the Tower, Sir 
George Harvey (c.1533-1605).  It was later reported by 
Figure 2. Portrait of Sir William Wadd (1546-1623)
(Unsigned copper engraving after a 17th century portrait 
‘published June 1st 1798 by W. Richardson, York House, 
No. 31 Strand’. Wikimedia Commons)
the rather less sympathetic Sir William Wadd (1546-
1623; Figure 2), James’s replacement for Harvey, that:
‘Sr Walter Raleigh hath like access of diuers to him, 
the doore of his chamber beinge alwais open all the 
day to the Garden, which indeed is the only Garden 
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the Lieuetenant hath, & in the Garden he hath con-
verted a little Hen-house to a still house, where he 
doth spend his time all the day, in his distillations,2’
Despite having been in charge of taking Raleigh to Win-
chester for trial, and acting as one of the three judges 
who convicted him, Waad does not seem to have placed 
any further restrictions on Raleigh’s movements until 
July 1607, when new ordinances demanded that all 
prisoners be returned to their chambers at around 5 pm, 
and should stay there for the remainder of the night. 
With the uncovering of the Gunpowder Plot in 
1605, Henry Percy, 9th Earl of Northumberland, joined 
Raleigh in the Tower; he was housed in the Martin 
Tower, but the two were able to spend time together, 
almost without restriction. Percy was often referred to 
as the ‘Wizard Earl’ because of his fondness for scien-
tifi c investigation. He brought with him an extensive 
scientifi c and occult library, and gathered around him-
self and Raleigh a coterie of scientists, three of whom, 
collectively formed what was known as the ‘Th ree 
Magi’: these were Th omas Harriot (1560-1621; explor-
er and eminent mathematician), Walter Warner (1563-
1643, chemist), and Robert Hues (1553-1632, mathe-
matician and geographer).3
It has been argued that this group of experimental 
researchers, sponsored by Percy and Raleigh, represents 
the transitional moment from the still-magical theories 
of Giordano Bruno to real science.4 Percy, it seems, was 
much more fi nancially secure than Raleigh, who had 
had all of his assets seized following his arrest. Percy ac-
cordingly funded the further development of a labora-
tory located in the hen-house, as the household ac-
counts for Alnwick Castle show.5
What did Raleigh do in the hen-house laboratory? 
Alchemical experiments must have fi gured prominent-
ly, as much of the equipment purchased for the labora-
tory was appropriate to the processes employed by the 
new ‘chymists’, such as distillation. Secondary manu-
script sources purportedly copied from Raleigh’s origi-
nals provide examples replete with alchemical symbols 
for various ingredients.6  Th ese same sources, which will 
be analysed separately to the present paper, include a 
number of medicinal receipts that attest to Raleigh’s ac-
tive interest in practical pharmacy. Amongst the arte-
facts associated with Raleigh is a small medicine chest, 
and this may well have been in his possession whilst in 
the Tower, since he is known to have treated a number 
of people whilst he was incarcerated there.
Raleigh’s medicine chest
Th e medicine chest (Figure 3) has survived, and it is 
held by the Museu da Farmácia, Rua Marechal Saldan-
ha, 1-1249-069 Lisbon, Portugal. It was acquired by 
the museum in 2005, is registered under Inv. 13612, 
and is currently on display in the galleries on the fi rst 
fl oor of the museum building. Oblong in shape, the 
longest side of the wooden box with its spreading foot 
measures 23.5cm (9.5 inches). Th e outer surface of the 
wood, including the domed lid and expanded foot,  is 
completely covered with plates of decorated silver gilt 
secured in place by metal pins. Th e foot is decorated 
with Acanthus leaves, while the front face is pierced for 
a keyhole, which is surrounded by a key escutcheon. 
Th e sides are chased with strap work, vases of fruit, 
scrolls, drapery and masks, and the back has a vacant 
oval cartouche enclosed by a beaded border. 
Th e lid is covered by a raised rectangular plaque 
chased with a grotesque mask and military and musical 
trophies, together with shells, scrolls, strap work, cornu-
copia, a snail and a grotesque mask border. Th e inside of 
the box, including the lid, is lined with red velvet, and 
there is an internal holder which accommodates twelve 
glass bottles with silver gilt lids secured to the bottle 
necks by means of short chains running from rings in 
the lid centres. 
Figure 3. Medicine chest of Sir Walter Raleigh
(Inv. 13612, Museu da Farmácia, Lisbon, Portugal, with 
detail of armorial above. Reproduced by kind permission 
of the Director of the Museum)
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Inside the box lid there is a prominent metal plate 
(Figure 4), secured by metal pins and carrying a distinc-
tive engraved armorial that is central to discussion 
about the original provenance and ownership of the 
chest.  Th e central part of the armorial is taken up with 
a shield or arms, which is divided into 16 quarterings. 
On either side of the shield of arms there is a wolf 
standing on its hind legs acting as a supporter. Th e top 
border of the shield of arms is surmounted by three 
helmets (or helms); the central example is full face (af-
frontry), facing the viewer, and the two side helms are 
depicted in profi le or lateral view, facing the centre and 
towards each other.  Each helmet has a visor that is 
closed. A cape hangs in open folds from the tops of the 
three helms, cascading down past the gorgets (portions 
of the helmet which rested on the shoulders), behind 
and to the sides of the shield of arms, terminating be-
low its lower border.  Each of the helms bears a crest. 
Th e crest on the fi rst helm is a fl eur-de-lis.  Th e middle 
helm bears a stag’s head caboshed with a fl eur-de-lis be-
tween the attires – in other words, a full frontal stag’s 
head without the neck, and a fl eur-de-lis placed be-
tween the two sets of antlers.  Th e third crest consists of 
a stag statant, that is, standing still with all four feet 
touching the ground.  At the foot of the armorial there 
is a scroll carrying an inscription of the motto ‘Amore et 
Virtute’ (Love and Virtue).
Establishing Provenance
Walter Raleigh was born in Devon as second son to 
Walter Ralegh Senior and his wife Katherine (née 
Champernowne).  Th e family lived at Hayes Barton 
and attended All Saints’ Church in nearby East Budle-
igh. In the church, the end of the family pew is deco-
rated with a carved armorial surrounded by Acanthus 
leaf foliage decoration and dated 1537. Th e armorial 
contains a few elements of that on the medicine chest; 
the shield is surmounted by a single open helm with 
gorget in profi le, and the two supporters are stylised 
wolves (Figure 5). Th e crest is a set of deer antlers.  
In the plaque on the medicine chest, the escutch-
eon, or shield, is divided into 16 quarterings.  Th e 
quarter in the top left hand corner shows fi ve fusils 
(elongated lozenges) arranged in a bend (i.e. conjoined 
in a line extending from the dexter corner to the op-
posite edge); this is the shield of the Raleigh family. Th e 
pattern is used in the silver commemorative seals pro-
duced by Crichton’s during the 19th century (Fig-
ure 6),7 but also in Raleigh’s Seal of Offi  ce and his own 
personal seal.8 
Figure 4. Line drawing of the armorial plate in the lid of 
Raleigh’s medicine chest
Figure 5. Carved armorial at the end of the Raleigh fam-
ily pew in All Saints’ Church, East Budleigh, Devon
Figure 6. Silver seal matrix of Sir Walter Raleigh
(British Museum, 1904, 0113.2)
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Th e remaining quarterings are associated with 
houses connected to the Raleigh line.9  Th e same sets of 
quarterings are present in two further variations of Ra-
leigh’s armorials, both published by Th omas Harriot, 
Raleigh’s fellow-prisoner in the Tower of London, per-
sonal associate, and an astronomer, mathematician and 
explorer of some renown.10 His skills and interests 
equipped him as a maritime navigator, and he visited 
the Roanake colony in Virginia, which was originally 
set up by Raleigh in response to a colonisation charter 
from Elizabeth I in 1584. 
Harriot was invaluable to the colony, having learned 
the Algonquin language. His account of the voyage to 
the colony in 1585-1586 was A briefe and true report of 
the new found land of Virginia, fi rst published in 1588.11 
Th e volume was dedicated to Raleigh and carried his 
armorial on the page following the title page (Figure 7). 
In the 1588 edition, the armorial is almost identical to 
that on the medicine chest, including the nature of the 
escutcheon, helms, crests, supporters, motto and even 
the presence of the cape.  Th e rather fi ner 1590 edition 
issued by the publisher, editor and engraver Th eodor de 
Bry (1528-1598; Figure 8) also carries the armorial, this 
time minus the cape and supporters but identical to that 
on the medicine chest in all other respects (Figure 9).12
profi le, crested by a crown and fl eur-de-lis.  Th e sixteen 
quarterings are identical to those on the medicine chest 
however, and the scroll bearing his motto is placed 
above the armorial rather than beneath it.
Th e fact that the original owner of the medicine 
chest was Sir Walter Raleigh is clearly indicated by 
these comparisons between the armorial crest on the 
interior of the chest lid, and both the material culture 
Figure 7. Raleigh Coat of Arms
(from Harriot 1588, see Note 11)
Whilst incarcerated in the Tower of London, Ra-
leigh embarked on a writing project of no small vision-
a complete history of the world, originally conceived as 
a fi ve volume set.  In the end, only the fi rst volume was 
issued, and published for the fi rst time in 1614.13 Th e 
title page of this edition has a portrait of Raleigh at the 
bottom (Figure 1), beneath which is his coat of arms, in 
this case with no supporters, and only a single helm in 
Figure 8. Portrait of Th eodor de Bry (1528-1598)
(self-portrait dated 1597, Wikimedia Commons)
Figure 9. Raleigh Coat of Arms
(from Harriot 1590, see Note 12)
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and contemporary published images of his armorial 
and motto.
Tudor medicine chests
Th e survival of Sir Walter Raleigh’s medicine chest is 
oustandingly fortuitous, especially since he was stripped 
of his assets following his trial and imprisonment. Th e 
twelve glass bottles would have been suitable for storing 
liquid or powdered materials. It is not at all clear 
whether they were used for individual simples, scented 
liquids or mixtures. Considering the small size and na-
ture of the chest, it is perhaps most likely that it would 
have been used as an item of personal or small-scale 
family use.
(Figure 11). Th e latter is a wooden box covered with 
bullion embroidery. Th e front panel bears the arms of 
the Bacon family of Redgrave in Suff olk and, like Ra-
leigh’s cabinet, has a background decoration of Acan-
thus leaves. Th e military medicine chest is an altogether 
more complex structure designed to house dozens of 
solid and liquid ingredients which could be used to 
produce the many combinations of simples which were 
needed to treat troops both on and off  the battlefi eld. 
Figure 10. Military medicine chest 1588
(Wellcome Library, London)
Figure 11. Early 17th century medicine chest
(Wellcome Library, London)
Unfortunately, there are few, if any survivals from 
the same period with which to compare the chest; a 
search of the literature and museum collections has 
only yielded details of a military chest from 1588 (Fig-
ure 10) and an early sevententh century family chest 
Conclusion
Th e medicine chest housed by the Museu da Farmácia 
in Lisbon undoubtedly belonged to Sir Walter Raleigh; 
provenance is clearly indicated by the engraved armo-
rial attached to the inside of the lid.  Th is specimen 
seemingly represents a unique personal or family sur-
vival from the time of Queen Elizabeth I, although the 
details of its contents and means of use remain obscure.
Acknowledgements
Th anks are due to Dr Maria do Sameiro Barroso (Lis-
bon) who kindly showed me great hospitality during 
my visit to Portugal. I should also like to express my 
deep gratitude to Drs João Neto and Paula Basso, both 
of the Museu da Farmácia, Lisbon, for discussion, be-
ing so helpful in my quest for further information 
about the chest held in their care, and for the provision 
of better photographic images than my own, together 
with permission to publish them.  Without their sup-
port, this paper could not have been written. Access to 
the Raleigh family pew at All Saints Church in East 
Budleigh was by permission of Rev. Anne Charlton.
https://doi.org/10.24355/dbbs.084-202007291100-0
38 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/2
Author’s Addresses: Dr Christopher J. Duffi  n, Sci-
entifi c Associate, Department of Earth Science, Palae-
ontology Section, Th e Natural History Museum, 
Cromwell Road, London SW7 5BD, UK, and 146 
Church Hill Road, Sutton, Surrey, SM3 8NF, England. 
Email: cduffi  n@blueyonder.co.uk
Endnotes and References
1. See for example Edwards, E. Th e Life of Sir Walter Ra-
leigh. Two volumes. London: Macmillan, 1868. Trevelyan, R. Sir 
Walter Raleigh. New York: Henry Holt & Co., 2002. Nicholls, 
M. and Williams, P. Sir Walter Raleigh in Life & Legend. London: 
Continuum, 2011.
2. Letter from Sir William Wade to Lord Salisbury, 1605 
Aug. 19th. Additional Manuscripts 6178, Folio 14. London: Brit-
ish Library. 
3. Shirley, JW. Th e scientifi c experiments of Sir Walter Ra-
leigh, the Wizard Earl, and the Th ree Magi in the Tower 1603-
1617. Ambix. 1949; 4 (1-2): 52-66.
4. Jacquot, J. Th omas Harriot’s reputation for impiety. 
Notes and Records of the Royal Society. 1952; 9: 164-187.
5. Shirley, JW. (Note 3) 1949, 61.
60 Raleigh, Sir Walter (& others). Receipt book. London: 
Wellcome Library. MS. 749-13.
7. Description of Seal: Circular silver seal-matrix of Sir 
Walter Raleigh, with a semi-circular hinged handle of smaller 
diameter pierced, with scrolls and a loop at the end. Th e arms of 
Raleigh, fi ve fusils in a bend with a martlet for diff erence a hel-
met and supporters, two wolves, mantling and crest, a stag; in 
the fi eld the date; below, motto on a scroll (Amore et Virtute). 
Inscription : * PROPRIA+ TNSIHNIA + WALTERI+ 
RALEGH+ MILITIS+ DOMINI+& GVBERNATORIS+ VIR-
GINIÆ+ &.; Dimensions: 57 mm diameter; weight 83g. Lon-
don: Britain, Europe and Prehistory Department, British Mu-
seum, 1904, 0113.2.
8. Tytler, PF. Life of Sir Walter Raleigh: Founded on Authen-
tic and Original Documents, Some of Th em Never Before Published: 
Including a View of the Most Important Transactions in the Reigns of 
Elizabeth and James I. Edinburgh, Oliver & Boyd, 1844, title 
page and facing page 159 respectively.
9. Edwards, E. (Note 1) 1868, opposite page 8.
10. Shirley, JW. Th omas Harriott: A Biography. Oxford: Clar-
endon Press, 1983.
11. Hariot, T. A briefe and true report of the new found land of 
Virginia: of the commodities there found and to be raysed, as well 
marchantable, as others for victuall, building and other necessarie uses 
for those that are and shalbe the planters there; and of the nature and 
manners of the naturall inhabitants : Discouered by the English Colony 
there seated by Sir Richard Greinuile Knight in the yeere 1585. which 
remained vnder the gouernement of Rafe Lane Esquier, one of her 
Maiesties Equieres, during the space of twelue monethes : at the speciall 
charge and direction of the Honourable S I R WA LTER R A LEIGH 
Knight, Lord Warden of the stanneries ; who therein hath beene fau-
oured and authorised by her Maiestie and her letters patents: Directed 
to the Aduenturers, Fauourers, and Welwillers of the action, for the in-
habiting and planting there. London, publisher not indicated, 1588.
12. Hariot, T. A briefe and true report of the new found land 
of Virginia: of the commodities; and of the nature and manners of the 
naturall inhabitants : Discouered by the English Colony there seated 
by Sir Richard Greinuile Knight in the yeere 1585. which remained 
vnder the gouernement of twelue monethes : at the speciall charge 
and direction of the Honourable S I R WA LTER R A LEIGH 
Knight, Lord Warden of the stanneries ; who therein hath beene fau-
oured and authorised by her Maiestie and her letters patents. Fran-
coforti ad Moenum, Th eodori de Bry, 1590.
13. Raleigh, W. Th e History of the World. London: Walter 
Burre, 1614.
https://doi.org/10.24355/dbbs.084-202007291100-0
 PHARMACEUTICAL HISTORIAN  ·  2017  ·  Volume 47/2 39
Moodeen Sheriff  and the 1869 Supplement 
to the Pharmacopoeia of India 1868
Harkishan Singh
Abstract
Moodeen Sheriff  was a distinguished Indian physician 
who died in 1892. Th is article outlines his life and ca-
reer, and describes his role in the preparation of the 
Pharmacopoeia of India 1868. He prepared a catalogue 
of Indian synonyms of medicinal plants as an appendix, 
but owing to printing delays it was published separately 
as a Supplement to the Pharmacopoeia of India in 1869. 
Sheriff  later supplied a collection of indigenous drugs 
for the Calcutta International Exhibition of 1883-84, 
and went on to write a Materia Medica of Madras, pub-
lished in 1891.
Introduction
In the late 1980s I changed direction from being a ped-
agogue and experimental scientist to become a science 
historian. I started studies on the pharmaceutical his-
tory of India of recent times. I visited the major archival 
centres in the country and abroad, and also carried out 
extensive correspondence to collect source material on 
the history of pharmaceutical developments in India 
during the last couple of centuries. Over several years 
an archival centre of my own started taking shape.1 In 
particular, suffi  cient source material became available 
on the pharmacopoeial history of India that publica-
tion of a monograph on the subject became possible.2 
Th rough this medium I was introduced to EJ Waring 
and Moodeen Sheriff , who respectively prepared the 
Pharmacopoeia of India (1868) and its Supplement 
(1869). I thought that I might write on their lives and 
contributions at some stage, and kept collecting source 
material during the decades that intervened. Recently, 
it became possible for me to complete a research paper 
on Waring.3
It seems that no deserved attention has been paid 
to the life and work of Moodeen Sheriff .4 I came across 
only one short note on him.5 It contained the follow-
ing information: 
“Mohideen Serif obtained diploma from the Ma-
dras Medical College, G.M.M.C. He joined subor-
dinate Medical Science in Madras and rose to high 
position of native surgeon. He was [a] very popular 
medical practitioner and served for many years as 
medical offi  cer in the Triplicane Dispensary, later 
Royapettah Hospital. He contributed many clinical 
reports to the Medical Journals. But his most out-
standing contribution was his compilation of a sup-
plement to the Indian Pharmacopoeia for which he 
was highly esteemed by the medical profession in 
Britain. He also made a valuable contribution by 
writing a book on the Materia Medica of Madras, 
giving the results of his wide study and experience 
on drugs available in the Madras Presidency. He 
was elected as a fellow of Madras University. Th e 
Government awarded him the titles of ‘Khan Baha-
dur’ and ‘Honorary Surgeon.’ He died in 1892 in 
Triplicane in his own house. A portrait of Mohi-
deen Sherif was hung in Royapettah Hospital.” 
Appended to the note were two extracts from the Re-
cords Offi  ce: the fi rst related to conferment on him of 
an honorary assistant surgeon title; the second con-
cerned the assignment of a duty to him for collecting 
specimens of native drugs for the Museum of the Royal 
Victoria Hospital, a large military hospital located at 
Netley near Southampton in southern England.
Th e career and publications of Moodeen Sheriff 
What was previously a Medical School was designated 
a Medical College in 1850, and the institution later be-
came Madras Medical College. Th ose who graduated 
from the College used to be granted diplomas, and the 
students so trained used to be referred to as G.M.M.C. 
(Graduate of Madras Medical College). Th is qualifi ca-
tion against the name of Moodeen Sheriff  appears over 
and over again in diff erent publications. He must have 
qualifi ed from the College at some stage in the 1850s. 
He joined the Triplicane dispensary in 1858, as this is 
stated in an annual report of the Triplicane Dispensary.6 
In the minutes of the Madras Medical Book Society, 
Sheriff ’s name appears as a Native Surgeon.7 He was the 
author of an independent paper on contraction, or ri-
gidity of muscles in paralysis, which was published in 
the  Madras Quarterly Journal of Medical Science,8 Sher-
iff ’s name appears on several of the annual reports of the 
Triplicane Dispensary.9-11
It may be of interest to note what Dr Sheriff  stated 
in an annual report: 
‘I am happy to state that my professional engage-
ments with people of all kinds in the 4th District 
have been very successful, particularly with Ma-
homedans, who resort to my treatment not only 
from all parts of [the] Presidency, but also from dis-
tant places.’9 For the favourable terms in which his 
professional services were held he was allowed an 
allowance of 150 rupees per mensem [month].12 
For the much appreciated professional services, a com-
mendable recognition came when Native Surgeon 
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Moodeen Sheriff  was conferred the rank of Honorary 
Assistant Surgeon.13,14 In the news on conferment of 
honorary rank, it was also stated, ‘Mr Moodeen Sheriff  
having been granted six months leave, has accompanied 
the son of the Prince Arcot on a tour to Mecca, Medi-
na, and Jerusalem.’14
Th e major publications of Moodeen Sheriff  were the 
Supplement (1869) to the Pharmacopoeia of India 
(1868) and the Materia Medica of Madras which, respec-
tively, constitute the succeeding sections of this article.
Th e Supplement to the Pharmacopoeia of India 
1868
It may be stated that while preparing the Pharmaco-
poeia of India reports from medical offi  cers and others 
were entertained. Among the returns received from In-
dia there was one from Native Surgeon Moodeen Sher-
iff  of Triplicane Dispensary, Madras. He furnished ver-
nacular names of indigenous plants and drugs in the 
Indian native languages. During 1867, Sheriff  was 
granted leave for four months, on special duty, to en-
able him to complete the work.15 Th e catalogue he pre-
pared was got checked from eminent oriental scholars, 
and it was decided to append it to the Pharmacopoeia 
of India. Th e printing, which was to be done at Madras 
under the supervision of Moodeen Sheriff , unexpect-
edly got delayed and as such it was considered advisable 
to publish this catalogue as a separate or supplementary 
volume.
Th e Supplement to the Pharmacopoeia of India was 
published in 1869.16 It was a catalogue of Indian syno-
nyms of the medicinal plants, products, inorganic and 
organic substances included in the Pharmacopoeia, 
with explanatory and descriptive remarks, in fourteen 
languages. In addition to English the other languages 
covered were Arabic, Persian, Hindustani, Dukhni, Ta-
mil, Telugu, Malayalam, Kannada, Bengali, Sanskrit, 
Marathi, Gujarati, Sinhalese, and Burmese. Several 
works which were consulted for preparing the cata-
logues are listed in the Supplement (pages 331-335). 
Th e catalogue was supplied with sixteen indexes: index 
of botanical names, index of English synonyms, and 
fourteen other indexes, one for each language, to facili-
tate the reference of every name included in it.
A contemporary review was all praise for the Supple-
ment but critical of the Pharmacopoeia of India 1868.17 
It was said about the Pharmacopoeia ‘that we have all 
been somewhat disappointed with the work’ and it was 
regarded more ‘as a handbook of materia medica than a 
Pharmacopoeia.’ It was the view ‘that Dr Waring shirked 
one of the most diffi  cult, and at the same time, most 
important parts of his work, when he transferred to Mr 
Moodeen Sheriff  the execution of the portion that now 
appears as a Supplement.’ Sheriff  was complimented for 
the laborious task he accomplished. It was stated:
‘Altogether, the Supplement has been prepared with 
great care, is highly creditable to its author, and will 
be of very great practical value in this country. But 
for its appearance the Pharmacopoeia of India must, 
to a great extent, have remained a dead letter.17’
Kanny Lall Dey, a well reputed and respected expert on 
indigenous drugs during the nineteenth century, said in 
his presidential address at the Section of Pharmacology 
of the Indian Medical Congress (1894) that:
Following O’Shaughnessy’s Bengal Pharmacopoeia 
(1844), the publication of the Pharmacopoeia of 
India (1868) under the editorship of Dr Waring sig-
nalized a new epoch in the establishing of the value 
of indigenous medicinal products. Th e more im-
portant were stamped with some measure of offi  cial 
recognition, a preliminary step to the ultimate 
Figure 1: Title page of the 1869 Supplement to the Phar-
macopoeia of India 1868
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adoption of several in the British Pharmacopoeia, a 
distinction of which many more – as I shall hope to 
show – are equally worthy. Dr Moodeen Sheriff ’s 
‘Supplement to the Pharmacopoeia’ published in 
the following year added very materially to the use-
fulness of that work.18
Materia Medica of Madras 1891
Moodeen Sheriff  had rich experience in the use of In-
dian medicinal plants. He had previously prepared the 
Supplement to the Pharmacopoeia of India. Later he had 
supplied a collection of indigenous drugs of the Madras 
Presidency for the Calcutta International Exhibition 
held in 1883-84. Out of his involvement on catalogu-
ing the drugs was born the idea of preparing a book on 
the materia medica of Madras.19
In the Preface20 to the book Sheriff  wrote: 
‘As the medicinal properties of the drugs mentioned 
in this book are solely from my own experience and 
knowledge, and not gleaned or borrowed from any 
other work, English or Native, the greatest thing I 
was in need of writing it, was the trial of those drugs 
in various diseases. I was amply supplied with this 
need by my being attached to the Triplicane Dis-
pensary, where I had every morning prescribed for 
about 100 out-patients, and was thus enabled to 
select some cases every day for trial. Th is was the 
chief resource I depended upon in writing a book of 
this nature, and its deprivation in consequence of 
my retirement from the service on 7 July 1889 is 
very deplorable and a death-blow to my undertak-
ing.’
It appears that Sheriff  started working on the book 
right after supplying a collection of drugs for the Cal-
cutta International Exhibition 1883-84, since he writes 
in the Preface: ‘Th e delay of six or seven years in writing 
this book might appear to be great or unusual at fi rst 
sight, but it is not really so when we consider that it is 
chiefl y based upon actual trials of drugs, as I have just 
explained.’
…‘Another circumstance which added to this delay 
was my own health, which was somewhat impaired 
after I commenced to write this work, and I was laid 
up twice with paralysis during its progress.’
Because of unavoidable circumstances the Government 
of Madras agreed to his wishes and issued orders to the 
Government Press for publication of Volume I of the 
Materia Medica of Madras. ‘Th e numbers of articles in 
this work correspond with those of the drugs I forward-
ed to the Calcutta International Exhibition 1883-84, 
but there are many medicines to which no numbers are 
prefi xed.’
Since the readers of this article are unlikely to have 
ready access to the book, I may mention the way par-
ticulars for each of the entries in the book are provided: 
Botanical name of the drug and numbers: Habitat; 
Parts used; Synonyms; Local sources; Price; Physiological 
Actions Active Principle; Th erapeutic Uses; Preparations; 
Dose; European Drugs for which it may be substituted; 
Remarks. 
Th e preface bears the signature of MOHIDEEN 
SHERIFF KHAN BAHADUR. It is dated January 
1891 and the book was published in Madras. At the 
bottom there is a Note: 
‘Owing to the death of Dr Mohideen Sheriff  on the 
21st February 1891, the Government of Madras has 
accepted with pleasure the off er of Mr David 
Hooper, Government Quinologist, Ootacamund, 
to edit and complete the Materia Medica of Madras 
(G. O., No. 371, dated 9th May 1891, Public De-
partment).’21Figure 2: Title page of Materia Medica of Madras 1891
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Conclusion
In my elaborate correspondence for the particulars on 
Moodeen Sheriff  a letter of mine reached Professor Ha-
kim Syed Khaleefathullah, Hony. Physician to the Pres-
ident of India, through the Vice-Chancellor of the Dr 
MGR Medical University, Madras. Professor Khaleef-
athullah in his reply to me on 22 March 1991 stated, 
‘According to my personal knowledge and also detailed 
enquiry the name of Dr Moodeen Sheriff  as mentioned 
by you in your letter did not exist in Triplicane Area.’ 
My postal enquiries from several of the institutions 
and other individuals were also not fruitful. Moodeen 
Sheriff  was lost to history, until I started an organized 
study of the subject through my personal visits to dif-
ferent archival centres in India. But for locating Supple-
ment to the Pharmacopoeia of India at the Calcutta 
Medical College Library, the other source material on 
the subject cited above became available to me on visits 
to Madras and working at the Connemara Public Li-
brary/Tamil Nadu Archives.
Now we have documented evidence to show that 
Moodeen Sheriff  graduated from the Madras Medical 
College at some stage in 1850s, joined the Triplicane 
Dispensary in 1858,6 retired on 7 July 1889,20 and 
passed away on 21 February 1891.21 One can only ex-
trapolate his year of birth; I have not come across any 
recorded information on the account.
Basu (IMS)22 noted as far back as 1892 that ‘the 
establishment of Medical Colleges and Schools in the 
country also advanced our knowledge of indigenous 
drugs. Th e graduates whom the colleges turned out di-
rected their attention to the subject. Kanny Lall Dey,23 
Udoy Chand Dutt,24 Moodeen Sheriff  and several oth-
er graduates of the Indian Medical Colleges were not 
slow in recognizing the importance of the subject of 
indigenous drugs. Basu25 further wrote: 
‘Moodeen Sheriff  will always occupy a prominent 
place amongst the workers of indigenous drugs. His 
supplement to the Pharmacopoeia established his 
reputation as a pharmaceutist of no mean order. 
His posthumous work on Materia Medica of Ma-
dras edited by Hooper, has brought our informa-
tion on indigenous drugs of that Presidency up to 
date.’
Finally, a mention may be made of the endowment 
of Rs 761 made by friends of Dr Mohideen Sheriff , and 
Government sanctioning additional grant of Rs 381, 
for instituting a prize at the Madras Medical College, in 
memory of Dr Sheriff .26
Author’s address: Professor Emeritus Harkishan Singh, 
Pharmaceutical Sciences, Panjab University, 1135 Sec-
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D O C U M E N T S  A N D  S O U R C E S
A note on clinical judgment and 




Repeated concerns and criticisms exist over the discard-
ing of books by university and other academic libraries. 
Reasons given include ‘being out-of-date’, lack of read-
ership, and space needed for computers. Twentieth-
century books, mostly from the 1930s to the 1980s, 
not ‘rare’ but often unavailable as digital copies, suff er 
more than others.
One target for discard, even if pre-1900, has been 
the small hospital and insurance pharmacopoeias as 
well as related drug tariff  booklets. All are sometimes 
inappropriately described as ephemera. Since antiquar-
ian book dealers have little interest in them, I acquired 
a small collection almost entirely from give-aways and 
discards. Should libraries save them? What value are 
they to the historian? My answer is that, besides the 
relevance of specifi c items to local history, all add per-
spective to such interrelated themes, noted below, as (i) 
professional judgment and authority, (ii) education, 
and (iii) standardisation of formulae and medicaments.
the Skin (1858) proclaimed that the ‘practical experi-
ence’ behind the entries was based on 
‘upwards of EIGHTY-ONE THOUSAND CASES 
recorded in the writer’s hospital books, in addition 
to more than EIGHT THOUSAND in those of 
[assistant surgeon] Mr. McWhinnie.’2 
A few years later, Peter Squire, in his Th e Pharmacopoe-
ias of Th irteen of the London Hospitals (1863), focused 
more on standardisation. He hoped that hospital au-
thorities, when revising their pharmacopoeias, would 
modify many formulae to accord with the new British 
Pharmacopoeia.3 
One commentator, who supported standardisation 
from a diff erent point of view, pointed out that Squire 
needed ‘over 152 pages’ to cover 13 hospitals, an indi-
cation of the relatively few formulae common to vari-
ous hospitals. Th e situation was seen as especially prob-
lematic for hospital medical students who would leave 
with
‘Th e most obscure notions of therapeutics in gen-
eral [and] no practical knowledge whatever of the 
doses on which simple drugs ought to be prescribed 
under varying conditions’.
Indeed, hospital prescribing cast ‘a veil of mystery over 
the treatment of patients.’4 Maybe the writer had in 
mind the Pharmacopoeia of the London Hospital for Dis-
eases of the Skin (1858), which, although ‘published for 
the use of students’ – a recognised role for all hospital 
pharmacopoeias – acknowledged that some formulae 
were, in fact, ‘household words’ that, once adopted, be-
came ‘diffi  cult, if not inexpedient, to change.’5
Although calls for standardisation had some infl u-
ence on hospitals – for example, the St. Bartholomew’s 
1900 Pharmacopoeia, made changes to accord with the 
1898 British Pharmacopoeia – diversity persisted due 
mostly to diff erences of opinion among physicians. 
Diff ering opinions, perhaps resolved by the authority 
of senior physicians rather than by consensus, were re-
fl ected in the many local or regional insurance pharma-
copoeias issued during the second and third decades of 
the 1900s subsequent to the 1911 National Insurance 
Act.6 For instance, while ‘antiseptic gargle’ was ignored 
by many pharmacopoeias, insured workers in Leicester 
during the ’teens and ’twenties might be prescribed 
such a gargle that looked diff erent from one off ered to 
their family members who were registered with the 
Leicester Public Medical Service with its own pharma-
copoeia.7
Amid the infl uences from the British Pharmacopoe-
ia, the British Pharmaceutical Codex (from 1923) and 
Figure 1: Examples of British hospital pharmacopoeias 
1858-1929
Hospital pharmacopoeias and standardisation
Th e New Practical Formulary of Hospitals (1835), a 
compilation and ‘pocket remembrancer’, refl ected the 
growing authority of hospital medicine through the 
ability to observe large numbers of patients.1 In fact, 
the Pharmacopoeia of the London Hospital for Diseases of 
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vigorous pharmaceutical company promotion of an in-
creasing range of new drugs, the precise impact of hos-
pital pharmacopoeias in standardising prescribing prac-
tices is diffi  cult to ascertain. Th is is underscored by 
their awareness, even concern, not to curtail a physi-
cian’s therapeutic judgment. Insurance pharmacopoeias 
were also sensitive to this. For instance, while making 
clear the importance of economy, the London Insur-
ance Committee (1915) indicated that, while it hoped 
that its Pharmacopoeia would facilitate the work of the 
panel practitioner, it was ‘in no way intended to restrict 
the character of the medical treatment given to the in-
sured population.’8
Hospital pharmacopoeias and clinical judgment
Later, the fi rst National Formulary for National Health 
Insurance Purposes (1929), after indicating that some 
doctors were frustrated in having to use several Insur-
ance formularies, recognised a general level of symp-
tomatic treatment when noting that the new formulary 
contained a ‘suffi  cient number of varied prescriptions 
to cover the treatment of cases of disease in which 
marked individuality of treatment is not required.’ On 
the other hand, the compilers of the Formulary, which 
was published under the auspices of the British Medical 
Association, stated ‘there is no wish to stereotype prescrib-
ing and any practitioner can write extemporaneous pre-
scriptions, whenever he desires, independently of the Na-
tional Formulary or of the Tariff .’ 9 A noteworthy 
side-issue was the strong reaction of the pharmaceutical 
industry to the Formulary’s hope of reducing the use of 
proprietary brands by listing ‘non-proprietary substance[s] 
of reputed analogous therapeutic eff ect’.10
Although this protection of therapeutic judgment 
was assumed to continue with the fi rst edition of the 
National [War] Formulary (1941), it was not expressed 
as such, merely that the ‘selection of medicines suffi  cient 
in range to meet the ordinary requirements of therapeu-
tics.’11 Th e successor, the British National Formulary 
(fi rst edition 1949), focused on quality and uniformity 
as it came to set aside those preparations deemed as less 
eff ective.12 It is tempting to ask whether the profession-
al aspirations of the pharmacists involved in this and 
successive editions infl uenced a shift to national stand-
ards and ‘drug information’ as distinct from the broad 
issues of therapeutics.13
Conclusion
While the prefatory remarks in many hospital and in-
surance pharmacopoeias specifi cally illuminate trends 
to uniformity in prescribing amid the demands of indi-
vidual treatment, others are silent on this. Nevertheless, 
all such pharmacopoeias prompt questions, not only 
about the signifi cance of the hand-written annotations 
or formulae generally found on interleaved blank pages 
(sometimes hinting at a consultant’s favoured formula), 
but also the social and other factors that contributed to 
mainstream usage of many preparations. 
Although favourite treatments, some unoffi  cial, still 
have a place in today’s therapeutics, they are less evident 
amid the pressures for uniformity that include a pleth-
ora of ‘guidelines’ (sometimes interpreted as policies) 
that tend to swamp considerations of individualised 
care. No wonder, in recollecting the past, physicians’ 
calls for ‘freedom to prescribe’ are commonly heard.
Small hospital and insurance pharmacopoeias can 
be of considerable value to the medical and pharmaceu-
tical historian, far beyond their often tattered, non-de-
script appearance. Perhaps the latter, along with the 
constant appearance of revised editions, infl uence li-
brary decisions to discard them, albeit to the detriment 
of understanding fully the complexity of therapeutic 
change and the resistance to it.
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